NANX News Alert Nanophase Technologies Corp. (NANX) 0.4422 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nanophase Technologies Corp. (NANX) 0.4422 $NANX

Nanophase Technologies Announces Year End 2014 Financial Conference Call
GlobeNewswire - Wed Feb 11, 3:06PM CST
Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today announced the Company will disseminate a financial news release for fiscal year 2014 on Wednesday, February 18, 2015, at 3:00 p.m. CST, 4:00 p.m. EST. The news release will be followed by the year-end financial conference call on Thursday, February 19, 2015, at 10:00 a.m. CST, 11:00 a.m. EST.

Nanophase to Highlight Optical Polishing Solutions at 2015 Photonics West Conference
PRWeb - Tue Jan 27, 4:26PM CST
Nanophase Technologies Corporation announced today that it will highlight its cerium oxide and aluminum oxide optical polishing slurries at Photonics West 2015, Jan. 10-12 in San Francisco.

Global Nanoparticle Market Outlook 2015-2020
M2 - Tue Jan 06, 10:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/kp9v5d/global) has announced the addition of the "Global Nanoparticle Market Outlook 2020" report to their offering. The global nanoparticle market is showing tremendous growth backed by nanoparticle development programs, research initiatives, government support and commercial demand for nanoparticles. The nanoparticle industry at present has reached an intermediate stage where it is gradually leaving laboratories and coming into commercial usage among consumers. The industry is witnessing massive investments from private companies and federal associations and is poised to achieve new heights with growing applications in various fields. Global Nanoparticle Market Outlook 2020, analysts have identified the speedy research and development activities that are driving nanoparticles globally. It is anticipated that the market will grow at a CAGR of 16% during 2015-2020. Our analysts have further identified the major emerging trends and the key challenges confronted by the Industry. The report provides detail information, reliable statistics, comparable data, and prudent analysis of the global nanoparticle market. It provides deep insight into the market by segment and by application. Through this report, our analysts have done a thorough opportunity assessment of various sectors and highlighted the future directions of the market. The report is an attempt to give a comprehensive view of the topic by also providing regional analysis on the subject. Further, it includes a fair account of technological advancements that have taken place on the global stage. A thorough understanding of the major players, their business overviews and financials are presented in the report. Overall, the objective of the study is to help clients understand the prospects of the industry, and make sound investment decisions in view of the same. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Key Industry Trends and Drivers 4. Nanoparticle Market Outlook to 2020 5. Industry Analysis by Vertical 6. Global Competition Analysis 7. Technological Advancements 8. Key Players - Altair Nanotechnologies - Bayer MaterialScience - Nanocomp - Nanophase Technologies Corporation - Nanosys Inc - Unidym, Inc - Zyvex Corporation For more information visit http://www.researchandmarkets.com/research/kp9v5d/global

Nanophase Technologies' (NANX) CEO Jess Jankowski Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:29PM CST


Nanophase's net loss narrows to USD0.3m in Q3 2014
M2 - Wed Nov 05, 5:05AM CST
Nanomaterials company Nanophase Technologies (Other OTC:NANX) stated on Tuesday its net loss USD0.3m (USD0.01 per share) for the third quarter ended 30 September 2014.

Nanophase Technologies -$0.01
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:08PM CST


Nanophase Reports Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 3:01PM CST
Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for the third quarter and nine months ended September 30, 2014.

Nanophase reports November 4
Seeking Alpha - at Seeking Alpha - Sat Nov 01, 4:56PM CDT


Nanophase Technologies Announces Third Quarter 2014 Financial Conference Call
GlobeNewswire - Wed Oct 22, 10:37AM CDT
Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today announced the Company will disseminate a financial news release for the third quarter of 2014 on Tuesday, November 4, 2014, at 3:00 p.m. CST, 4:00 p.m. EST. The news release will be followed by the third quarter financial conference call on Wednesday, November 5, 2014, at 10:00 a.m. CST, 11:00 a.m. EST.

NANX, ARO, OME, NLS, BMR, CWZ Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Thu Sep 18, 4:09AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of NANOPHASE TECHNOLOGIES CORP (OTC:NANX), Aeropostale Inc (NYSE:ARO), Omega Protein Corp (NYSE:OME), Nautilus Inc (NYSE:NLS), BioMed Realty Trust Inc (NYSE:BMR), Lehman ABS Corp (NYSE:CWZ) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BMR: 22.85 (-0.13), OME: 11.03 (+0.01), CWZ: 25.90 (-0.05), ARO: 3.63 (+0.04), NLS: 15.38 (+0.12)

Nanophase Reports Second Quarter 2014 Financial Results
GlobeNewswire - Wed Jul 30, 3:00PM CDT
Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for the second quarter and six months ended June 30, 2014.

Nanophase Technologies Announces Second Quarter 2014 Financial Conference Call
GlobeNewswire - Thu Jul 17, 10:00AM CDT
Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today announced the Company will disseminate a financial news release for the second quarter of 2014 on Wednesday, July 30, 2014, at 3:00 p.m. CDT, 4:00 p.m. EDT. The news release will be followed by the second quarter financial conference call on Thursday, July 31, 2014, at 10:00 a.m. CDT, 11:00 a.m. EDT.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading